These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 34793290)

  • 1. A novel panel of blood-based microRNAs capable of discrimination between benign breast disease and breast cancer at early stages.
    Sadeghi H; Kamal A; Ahmadi M; Najafi H; Sharifi Zarchi A; Haddad P; Shayestehpour B; Kamkar L; Salamati M; Geranpayeh L; Lashkari M; Totonchi M
    RNA Biol; 2021 Nov; 18(sup2):747-756. PubMed ID: 34793290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum microRNA as potential biomarker to detect breast atypical hyperplasia and early-stage breast cancer.
    An X; Quan H; Lv J; Meng L; Wang C; Yu Z; Han J
    Future Oncol; 2018 Dec; 14(30):3145-3161. PubMed ID: 30220214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating microRNAs from the miR-106a-363 cluster on chromosome X as novel diagnostic biomarkers for breast cancer.
    Li M; Zhou Y; Xia T; Zhou X; Huang Z; Zhang H; Zhu W; Ding Q; Wang S
    Breast Cancer Res Treat; 2018 Jul; 170(2):257-270. PubMed ID: 29557526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of non-invasive biomarkers for chronic atrophic gastritis from serum exosomal microRNAs.
    Liu H; Li PW; Yang WQ; Mi H; Pan JL; Huang YC; Hou ZK; Hou QK; Luo Q; Liu FB
    BMC Cancer; 2019 Feb; 19(1):129. PubMed ID: 30736753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Signature of Four Circulating microRNAs as Potential Biomarkers for Diagnosing Early-Stage Breast Cancer.
    Itani MM; Nassar FJ; Tfayli AH; Talhouk RS; Chamandi GK; Itani ARS; Makoukji J; Boustany RN; Hou L; Zgheib NK; Nasr RR
    Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34204158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Underexpression of circulating miR-145-5p and miR-133a-3p are associated with breast cancer and immunohistochemical markers.
    García-Magallanes N; Beltran-Ontiveros SA; Leal-León EA; Luque-Ortega F; Romero-Quintana JG; Osuna-Ramirez I; Barbosa-Jasso M; Arámbula-Meraz E
    J Cancer Res Ther; 2020; 16(6):1223-1228. PubMed ID: 33342777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of circulating MiR-30b-5p identifies advanced breast cancer.
    Estevão-Pereira H; Lobo J; Salta S; Amorim M; Lopes P; Cantante M; Reis B; Antunes L; Castro F; Palma de Sousa S; Gonçalves CS; Costa BM; Henrique R; Jerónimo C
    J Transl Med; 2019 Dec; 17(1):435. PubMed ID: 31888645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a six-microRNA signature as a potential diagnostic biomarker in breast cancer tissues.
    Mahmoudian M; Razmara E; Mahmud Hussen B; Simiyari M; Lotfizadeh N; Motaghed H; Khazraei Monfared A; Montazeri M; Babashah S
    J Clin Lab Anal; 2021 Nov; 35(11):e24010. PubMed ID: 34528314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential value of circulatory microRNA10b gene expression and its target E-cadherin as a prognostic and metastatic prediction marker for breast cancer.
    Dwedar FI; Shams-Eldin RS; Nayer Mohamed S; Mohammed AF; Gomaa SH
    J Clin Lab Anal; 2021 Aug; 35(8):e23887. PubMed ID: 34264524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.
    Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X
    World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. microRNA expression profiling on individual breast cancer patients identifies novel panel of circulating microRNA for early detection.
    Hamam R; Ali AM; Alsaleh KA; Kassem M; Alfayez M; Aldahmash A; Alajez NM
    Sci Rep; 2016 May; 6():25997. PubMed ID: 27180809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined detection of plasma miR-127-3p and HE4 improves the diagnostic efficacy of breast cancer.
    Lu M; Ju S; Shen X; Wang X; Jing R; Yang C; Chu H; Cong H
    Cancer Biomark; 2017; 18(2):143-148. PubMed ID: 27983524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A five-miRNA panel in plasma was identified for breast cancer diagnosis.
    Li M; Zou X; Xia T; Wang T; Liu P; Zhou X; Wang S; Zhu W
    Cancer Med; 2019 Nov; 8(16):7006-7017. PubMed ID: 31568692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel circulating microRNA signature as a potential non-invasive multi-marker test in ER-positive early-stage breast cancer: a case control study.
    Kodahl AR; Lyng MB; Binder H; Cold S; Gravgaard K; Knoop AS; Ditzel HJ
    Mol Oncol; 2014 Jul; 8(5):874-83. PubMed ID: 24694649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of color Doppler ultrasound combined with plasma miR-21 and miR-27a in the diagnosis of breast cancer.
    Li M; Li Q; Yin Q; Wang Y; Shang JM; Wang LH
    Clin Transl Oncol; 2021 Apr; 23(4):709-717. PubMed ID: 33206330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A two-miRNA signature of upregulated miR-185-5p and miR-362-5p as a blood biomarker for breast cancer.
    Zhang K; Wang YY; Xu Y; Zhang L; Zhu J; Si PC; Wang YW; Ma R
    Pathol Res Pract; 2021 Jun; 222():153458. PubMed ID: 33962174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Five serum-based miRNAs were identified as potential diagnostic biomarkers in gastric cardia adenocarcinoma.
    Wang J; Zhang H; Zhou X; Wang T; Zhang J; Zhu W; Zhu H; Cheng W
    Cancer Biomark; 2018; 23(2):193-203. PubMed ID: 30198863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma microRNA ratios associated with breast cancer detection in a nested case-control study from a mammography screening cohort.
    Chiorino G; Petracci E; Sehovic E; Gregnanin I; Camussi E; Mello-Grand M; Ostano P; Riggi E; Vergini V; Russo A; Berrino E; Ortale A; Garena F; Venesio T; Gallo F; Favettini E; Frigerio A; Matullo G; Segnan N; Giordano L
    Sci Rep; 2023 Jul; 13(1):12040. PubMed ID: 37491482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating miR-99a-5p Expression in Plasma: A Potential Biomarker for Early Diagnosis of Breast Cancer.
    Garrido-Cano I; Constâncio V; Adam-Artigues A; Lameirinhas A; Simón S; Ortega B; Martínez MT; Hernando C; Bermejo B; Lluch A; Lopes P; Henrique R; Jerónimo C; Cejalvo JM; Eroles P
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33050096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentiality of a triple microRNA classifier: miR-193a-3p, miR-23a and miR-338-5p for early detection of colorectal cancer.
    Yong FL; Law CW; Wang CW
    BMC Cancer; 2013 Jun; 13():280. PubMed ID: 23758639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.